She ended up going into urgent care that night on the side effects, she is very dizzy; I had a reaction to it, real dizzy I went to the ER, went to the urgent care that night; difficulty in speech; I have also had cancer this year; This is a spontaneous report from a contactable other hcp (patient) via Pfizer-sponsored program. A 63-years-old female patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 28Jan2021 (Batch/Lot Number: EN5318) (age at vaccination 63 years) as dose 2, single and via an unspecified route of administration on 06Jan2021 (Batch/Lot Number: EK4176) (age at vaccination 63 years) as dose 1, single both doses for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received booster dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection Lot number: Not reported) via an unspecified route of administration on an unspecified date as booster dose number unknown, single for COVID-19 immunization. It was reported that she got both doses and her booster dose but for first dose she ended up going into urgent care that night on the side effects, she was very dizzy on to she like to report that adverse event. She was also asking to see financial assistance program due to those side effects. She had spent 7000 dollars on urgent care. She did not give her information on that. She stated, she had vaccination on 28Jan2021 and she had both and the booster, she was a female she had full work, she had them all and on the 28th she had a reaction to it, real dizzy she went to the ER, went to the urgent care that night on 28Jan2021. They coded the bill to an ER visit and she got bill for 7000 dollars. she was wondering if you have any kind of financial assistance program through Pfizer that helps pay for those bills from the reaction to the vaccination. She was a CNA. Received vaccine through work on 29Jan2021. That evening went to Urgent care for dizziness and difficulty in speech on 28Jan2021. Does Pfizer have a legal department that could review her bill due to the reaction and help with some funds. Due to tremendous financial stress she was asking for pfizer intervention. She also had cancer this year on an unspecified date in 2021, and currently had an uninsured driver wreck her car. She would appreciate any help. This was mandated by her work. She had received all vaccines and feel as a health care worker her choice of work puts her in the position to protect her clients. Seriousness of the event she also had cancer this year was medically significant and other events was non serious. The patient underwent lab tests and procedures which included urgent care conducted tests: unknown results on an unspecified date in 2021. Therapeutic measures were taken as a result of adverse event she ended up going into urgent care that night on the side effects, she was very dizzy; she had a reaction to it, real dizzy she went to the ER, went to the urgent care that night and difficulty in speech which included pumped fluids in her, after a few hours better. Adverse event she ended up going into urgent care that night on the side effects, she was very dizzy; she had a reaction to it, real dizzy she went to the ER, went to the urgent care that night and difficulty in speech resulted in Emergency room visit. The outcome of the event she ended up going into urgent care that night on the side effects, she was very dizzy; she had a reaction to it, real dizzy she went to the ER, went to the urgent care that night and difficulty in speech was recovered on an unspecified date in 2021 and she have also had cancer this year was unknown.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events of cancer. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate